• Title/Summary/Keyword: Cessation

Search Result 976, Processing Time 0.028 seconds

Process of Cultivating Energy in Middle Aged Women Practicing Dan Jeon Breathing (단전호흡을 하는 중년여성의 기운 기르기 과정)

  • Kim, Kyung-Won
    • Women's Health Nursing
    • /
    • v.13 no.3
    • /
    • pp.174-183
    • /
    • 2007
  • Purpose: The purpose of this study was to explore the process of cultivating energy in middle-aged women doing Dan Jeon Breathing and to develop a grounded theory of Dan Jeon Breathing. Method: Data was collected by means of an in-depth interview using tape- recordings from 15 participants who practice Dan Jeon Breathing. The data was analyzed using the grounded theory method proposed by Strauss and Corbin(1998). Results: The core category was identified as "cultivating energy of the mind and the body together". The process of this could be further divided into 4 stages: the stages are cessation of an 'energetic life', 'depending on Dan Jeon Breathing', 'going through a difficult practice process' and 'getting used to Dan Jeon Breathing'. The participants began Dan Jeon Breathing because they were unable to retain their energetic lifestyle. They were dependent on Dan Jeon Breathing for recovery of health. Also, they were going through a difficult process. Finally, they entirely approved of Dan Jeon Breathing as a method of health promotion. Conclusion: This study provided the understanding needed for the training process of Dan Jeon Breathing. Therefore, women can pursue Dan Jeon Breathing for their health.

  • PDF

Clinical Features of Oxaliplatin Induced Hypersensitivity Reactions and Therapeutic Approaches

  • Bano, Nusrat;Najam, Rahila;Qazi, Faaiza;Mateen, Ahmed
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.17 no.4
    • /
    • pp.1637-1641
    • /
    • 2016
  • Oxaliplatin, a third generation novel platinum compound is the most effective first line chemotherapeutic agent for colorectal cancer (CRC) in combination with 5FU and leucovorin. It is indicated for pancreatic, gastric and testicular cancers combined with bevacuzimab, capecitabine, irinotecan and other cytotoxic agents. However, moderate to severe hypersensitivity reactions (HSR) during or after oxaliplatin infusion usually require cessation of chemotherapy or substitution of the key therapeutic drug which largely interferes with improved patient prognosis. This mini- review showcases recent and accepted opinions/approaches in oxaliplatin induced HSR management. Physicians and oncologists have varying attitudes regarding the decision to rechallenge the patient after an HSR experience, efficacy of desensitization protocols, effectiveness and selection of drugs for premedication and possibilities of cross sensitivity to other platinum agents (e.g. carboplatin). A brief insight into underlying molecular mechanisms and clinical manifestations of oxaliplatin induced HSR is offered. We have also discussed the management of oxaliplatin induced HSR and risk stratification for a successful and complete chemotherapeutic plan.

Clinical Problems in ML II and III: Extra-skeletal Manifestations

  • Park, Sung Won
    • Journal of mucopolysaccharidosis and rare diseases
    • /
    • v.2 no.1
    • /
    • pp.5-7
    • /
    • 2016
  • Mucolipidoses II and III alpha/beta (ML II and ML III) are lysosomal disorders in which the essential mannose-6-phosphate recognition marker is not synthesized onto lysosomal hydrolases and other glycoproteins. The disorders are caused by mutations in GNPTAB, which encodes two of three subunits of the heterohexameric enzyme, N-acetylglucosamine-1-phosphotransferase ML II, recognizable at birth, often causes intrauterine growth impairment and sometimes the prenatal "Pacman" dysplasia. The main postnatal manifestations of ML II include gradual coarsening of neonatally evident craniofacial features, early cessation of statural growth and neuromotor development, dysostosis multiplex and major morbidity by hardening of soft connective tissue about the joints and in the cardiac valves. Fatal outcome occurs often before or in early childhood. ML III with clinical onset rarely detectable before three years of age, progresses slowly with gradual coarsening of the facial features, growth deficiency, dysostosis multiplex, restriction of movement in all joints before or from adolescence, painful gait impairment by prominent hip disease. Cognitive handicap remains minor or absent even in the adult, often wheelchair-bound patient with variable though significantly reduced life expectancy. As yet, there is no cure for individuals affected by these diseases. So, clinical manifestations and conservative treatment is important. This review aimed to highlight the extra-skeletal clinical problems in ML II and III.

The Tense-Lax Question and Intraoral Air Pressure in English Stops

  • Kim, Dae-Won
    • Speech Sciences
    • /
    • v.9 no.4
    • /
    • pp.113-130
    • /
    • 2002
  • Measurements were made of pressure rise time (PoRT), voice cessation time, flattened peak intraoral air pressure (Po), pressure static time (PoST), pressure-fall time and the duration of oral closure as four English speakers uttered isolated nonsense $V_{1}CV_{2}$ words containing /b/ and /p/ ($V_{1}=V_{2}$ and the V was /$\alpha$/), with stress on either $V_{1}orV_{2}$ alternately. The hypothesis tested was: The tense stop consonant. will be characterized either by a higher Po or a longer PoST, and/or by both against lax. Findings: (1) PoRT was significantly greater in /b/ than /p/, (2) the voiceless stop /p/ produced generally greater mean Po, averaged across five tokens, than its voiced counterpart /b/, but statistically insignificant, and (3) altogether, across stress, tokens and subjects, the difference in the calculated pressure static time (PoSTc), i.e., PoST + PoRT, between /p/ and /b/ was highly significant (p $\leq$ 0.003). Although further investigations remain to be taken, the results strongly supported the linguistic hypothesis of tense-lax distinction, with /b/ being lax and /p/ tense. Airflow resistance at the glottis and supraglottal air volume are assumed to be responsible for much of difference in PoRT between /p/ and /b/. The PoSTc reflecting, although indirectly, the respiratory efforts during the oral closure of a stop, was a convincing phonetic parameter of the consonantal tenseness based on respiratory efforts. The effects of stress on Po and PoSTc were inconsistent, and the shorter PoRT than consonantal constriction interval was always accompanied by Po and PoST.

  • PDF

Characterization and Cofactor Binding Mechanism of a Novel NAD(P)H-Dependent Aldehyde Reductase from Klebsiella pneumoniae DSM2026

  • Ma, Cheng-Wei;Zhang, Le;Dai, Jian-Ying;Xiu, Zhi-Long
    • Journal of Microbiology and Biotechnology
    • /
    • v.23 no.12
    • /
    • pp.1699-1707
    • /
    • 2013
  • During the fermentative production of 1,3-propanediol under high substrate concentrations, accumulation of intracellular 3-hydroxypropionaldehyde will cause premature cessation of cell growth and glycerol consumption. Discovery of oxidoreductases that can convert 3-hydroxypropionaldehyde to 1,3-propanediol using NADPH as cofactor could serve as a solution to this problem. In this paper, the yqhD gene from Klebsiella pneumoniae DSM2026, which was found encoding an aldehyde reductase (KpAR), was cloned and characterized. KpAR showed broad substrate specificity under physiological direction, whereas no catalytic activity was detected in the oxidation direction, and both NADPH and NADH can be utilized as cofactors. The cofactor binding mechanism was then investigated employing homology modeling and molecular dynamics simulations. Hydrogen-bond analysis showed that the hydrogen-bond interactions between KpAR and NADPH are much stronger than that for NADH. Free-energy decomposition dedicated that residues Gly37 to Val41 contribute most to the cofactor preference through polar interactions. In conclusion, this work provides a novel aldehyde reductase that has potential applications in the development of novel genetically engineered strains in the 1,3-propanediol industry, and gives a better understanding of the mechanisms involved in cofactor binding.

A case of tacrolimus-induced encephalopathy after kidney transplantation

  • Kim, Myoung-Uk;Kim, Sae-Yoon;Son, Su-Min;Park, Yong-Hoon
    • Clinical and Experimental Pediatrics
    • /
    • v.54 no.1
    • /
    • pp.40-44
    • /
    • 2011
  • We present a case of tacrolimus-induced encephalopathy after successful kidney transplantation. An 11-year-old girl presented with sudden onset of neurologic symptoms, hypertension, and psychiatric symptoms, with normal kidney function, after kidney transplantation. The symptoms improved after cessation of tacrolimus. Magnetic resonance imaging (MRI) showed acute infarction of the middle cerebral artery (MCA) territory in the right frontal lobe. Three days later, she had normal mental function and maintained normal blood pressure with left hemiparesis. Follow-up MRI was performed on D19, showing new infarct lesions at both cerebral hemispheres. Ten days later, MRI showed further improvement, but brain single photon emission computed tomography (SPECT) showed mild reduction of uptake in both the anterior cingulate gyrus and the left thalamus. One month after onset of symptoms, angiography showed complete resolution of stenosis. However, presenting as a mild fine motor disability of both hands and mild dysarthria, what had been atrophy at both centrum semiovale at 4 months now showed progression to encephalomalacia. There are two points of interest in this case. First, encephalopathy occurred after administration of tacrolimus and improved after discontinuation of the drug. Second, the development of right-side hemiplegia could not be explained by conventional MRI; but through diffusion tensor imaging (DTI) and diffusion tensor tractography (DTT) of white matter tract, visualization was possible.

Management of Diabetic Foot Ulcer (당뇨병성 족부 궤양의 치료)

  • Seo, Dong-Kyo;Lee, Ho Seong
    • Journal of Korean Foot and Ankle Society
    • /
    • v.18 no.1
    • /
    • pp.1-7
    • /
    • 2014
  • In patients with diabetic foot, ulceration and amputation are the most serious consequences and can lead to morbidity and disability. Peripheral arterial sclerosis, peripheral neuropathy, and foot deformities are major causes of foot problems. Foot deformities, following autonomic and motor neuropathy, lead to development of over-pressured focal lesions causing the diabetic foot to be easily injured within the shoe while walking. Wound healing in these patients can be difficult due to impaired phagocytic activity, malnutrition, and ischemia. Correction of deformity or shoe modification to relieve the pressure of over-pressured points is necessary for ulcer management. Application of selective dressings that allow a moist environment following complete debridement of the necrotic tissue is mandatory. In the case of a large soft tissue defect, performance of a wound coverage procedure by either a distant flap operation or a skin graft is necessary. Patients with a Charcot joint should be stabilized and consolidated into a plantigrade foot. The bony prominence of a Charcot foot can be corrected by a bumpectomy in order to prevent ulceration. The most effective management of the diabetic foot is ulcer prevention: controlling blood sugar levels and neuropathic pain, smoking cessation, stretching exercises, frequent examination of the foot, and appropriate education regarding footwear.

Sorafenib-triggered radiation recall dermatitis with a disseminated exanthematous reaction

  • Oh, Dongryul;Park, Hee Chul;Lim, Ho Yeong;Yoo, Byung Chul
    • Radiation Oncology Journal
    • /
    • v.31 no.3
    • /
    • pp.171-174
    • /
    • 2013
  • Sorafenib is a multi-targeted kinase inhibitor, which is the current standard treatment for advanced hepatocellular carcinoma (HCC). Only one case of radiation recall dermatitis (RRD) associated with sorafenib has been reported so far. Our patient with recurrent HCC was treated with palliative radiotherapy (RT) for the chest wall mass. Sorafenib at 400 mg twice daily was begun on the day following RT. On the 14th day post-RT, an erythematous patch was observed on right chest wall which matched area previously irradiated. It was consistent with RRD. Ten days later, a disseminated exanthematous rash and severe pruritus occurred. Sorafenib was stopped and an oral antihistamine was prescribed to relieve symptoms. At the 1-week follow-up after the cessation of sorafenib, all symptoms were resolved. Physicians should be alert to this recall phenomenon as it can occur both in the skin and elsewhere and the occurrence of RRD may be unpredictable.

Efficacy of Recombinant Human Erythropoietin(rhu-EPO)

  • Kim, Dong-Hwan;Ahn, Byoung-Ok;Park, Jang-Hyeon;Lee, Sung-Hee;Kim, Won-Bae
    • Biomolecules & Therapeutics
    • /
    • v.6 no.3
    • /
    • pp.312-316
    • /
    • 1998
  • Efficacy and in vivo bioassay of recombinant human erythropoietin (rho-EPO), was investigated. Efficacy studies were conducted in normal, and cisplatin-induced anemic rats. Normal and anemic animals were treated intravenously with rhu-EPO for 5 days, and the changes in the number of red blood cells (RBC), hemoglobin concentration (Hb), hematocrit value (Hct) and percentage reticulocyte value (Ret, reticulocyte/RBC) were examined. In normal rats, rho-EPO significantly increased RBC, Hb, Hct and Ret at the doses of 50∼ 1,250 lU/kg/day in a dose-dependent fashion. Cisplatin-induced anemic rats showed significant increase of RBC, Hb, Hct and Ret after administration of rho-EPO (50-200 lU/kg/day) in a dose-dependent manner. These changes of hematological parameters disappeared gradually after cessation of the treatment. The in vivo bioassay results in polycythemic mice showed that rho-EPO had 90% of bioactivity compared to NIBSC standard rhu-EPO. These results suggest that rho-EPO might be useful for the therapy of anemia originated from renal failure and chemotherapy-induced anemia.

  • PDF

Phrenic Nerve Paralysis after Pediatric Cardiovascular Surgery (소아 심혈관수술 후의 횡격막마비)

  • 윤태진
    • Journal of Chest Surgery
    • /
    • v.25 no.12
    • /
    • pp.1542-1549
    • /
    • 1992
  • From March 1986 to August 1992, 18 patients underwent diaphragmatic plication for the diaphragmatic paralyses complicating various pediatric cardiac procedures. Age at operation ranged from 16 day to 84 months with mean age of 11.8 months. In order of decreasing incidence, the primary cardiac procedures included modified Blalock-Taussig shunt [ 5 ], Arterial switch operation [ 4 ], modified Fontan operation [ 2 ], and others [ 7 ]. The suspicious causes of phrenic nerve injury included overzealous pericardial resection [ 7 ], direct trauma during the procedure [ 6 ], dissection of fibrous adhesion around the phrenic nerve [ 3 ] and unknown etiology [ 2 ]. The involved sides of diaphragm were right in 10, left in 7 and bilateral in one. The diagnosis was suspected by the elevation of hem-idiaphragm on chest x-ray and confirmed by fluoroscopy. The interval between primary operation and plication ranged from the day of operation to 38 postoperative days [mean : 14 days]. The method of plication were "Central pleating technique" described by Schwartz in 16 and other techniques in 2. Five patients expired after plication and the cause of death were not thought to be correlated directly with the plication itself. In the remaining 13 survivors, extubation or cessation of positive ventilation could be done between the periods of the day of plication and 14th postoperative days [mean; 3.8day]. We have made the following conclusions : 1] Phrenic nerve paralyses are relatively common complication after pediatric cardiac procedures and the causes of phrenic nerve injury are mostly preventable; 2] Phrenic nerve palsy is associated with corisiderable morbidity; 3] diaphragmatic plication is safe, reliable and can be applicable in patients who are younger age and require prolonged positive pressure ventilation.ntilation.

  • PDF